Profit, you keep harping on medi progress, new customers, etc, but there is an internal cancer here with regards to share price, dilution, etc. Even ceo nick c cant fully explain it as it is complicated. But Once that is addressed, and then only, can all these great business developments can rightly move the stock.
News 
Market Data 
Discover 
